cell-free DNA (cfDNA) fragment size as a potential quantitative biomarker for metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Kang, Jun-Kyu [1 ]
Kim, Hwang-Phill [1 ]
Lim, Yoojoo [2 ]
Kim, Su Yeon [2 ]
Kim, Tae-You [3 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] IMBdx, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5164
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cell-free DNA (cfDNA) fragmentomes predict tumor burden in metastatic colorectal cancer (mCRC).
    Leal, Alessandro
    van 't Erve, Iris
    Lumbard, Keith
    Keefer, Laurel
    Carey, Jacob
    Wu, Tony
    Jakubowski, Debbie
    Butler, Denise
    Rongione, Michael
    Chesnick, Bryan
    Punt, Cornelis J. A.
    Meijer, Gerrit A.
    Dracopoli, Nicholas C.
    Maddala, Tara
    Scharpf, Robert
    Bach, Peter Brian
    Velculescu, Victor E.
    Fijneman, Remond
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Cell-free DNA and exoDNA analysis in metastatic colorectal cancer patients (mCRC).
    Galvano, Antonio
    Castiglia, Marta
    Guarini, Aurelia
    Gristina, Valerio
    Cutaia, Sofia
    Bazan, Viviana
    Russo, Antonio
    Carreca, Ignazio Ugo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Cell-free DNA concentration and fragment size as a biomarker for prostate cancer
    Emmalyn Chen
    Clinton L. Cario
    Lancelote Leong
    Karen Lopez
    César P. Márquez
    Carissa Chu
    Patricia S. Li
    Erica Oropeza
    Imelda Tenggara
    Janet Cowan
    Jeffry P. Simko
    June M. Chan
    Terence Friedlander
    Alexander W. Wyatt
    Rahul Aggarwal
    Pamela L. Paris
    Peter R. Carroll
    Felix Feng
    John S. Witte
    [J]. Scientific Reports, 11
  • [4] Cell-free DNA concentration and fragment size as a biomarker for prostate cancer
    Chen, Emmalyn
    Cario, Clinton L.
    Leong, Lancelote
    Lopez, Karen
    Marquez, Cesar P.
    Chu, Carissa
    Li, Patricia S.
    Oropeza, Erica
    Tenggara, Imelda
    Cowan, Janet
    Simko, Jeffry P.
    Chan, June M.
    Friedlander, Terence
    Wyatt, Alexander W.
    Aggarwal, Rahul
    Paris, Pamela L.
    Carroll, Peter R.
    Feng, Felix
    Witte, John S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).
    Woff, Erwin
    Kehagias, Pashalina
    Vandeputte, Caroline
    Kamoun, Tarek
    Guiot, Thomas
    Ameye, Lieveke
    Geboes, Karen Paula
    Delaunoit, Thierry
    Demolin, Gauthier
    Peeters, Marc
    D'Hondt, Lionel A.
    Janssens, Jos
    Carrasco, Javier
    Holbrechts, Stephane
    Goeminne, Jean-Charles
    Van Laethem, Jean-Luc
    Vergauwe, Philippe
    Paesmans, Marianne
    Flamen, Patrick
    Hendlisz, Alain
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Cell-free DNA in the Circulation as a Potential Cancer Biomarker
    Kohler, Corina
    Barekati, Zeinab
    Radpour, Ramin
    Zhong, Xiao Yan
    [J]. ANTICANCER RESEARCH, 2011, 31 (08) : 2623 - 2628
  • [7] Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment
    Pastor, Brice
    Andre, Thierry
    Henriques, Julie
    Trouilloud, Isabelle
    Tournigand, Christophe
    Jary, Marine
    Mazard, Thibault
    Louvet, Christophe
    Azan, Simon
    Bauer, Audrey
    Roch, Benoit
    Sanchez, Cynthia
    Vernerey, Dewi
    Thierry, Alain R.
    Adenis, Antoine
    [J]. MOLECULAR ONCOLOGY, 2021, 15 (09) : 2401 - 2411
  • [8] Circulating cell-free DNA in serum as a biomarker of colorectal cancer
    da Silva Filho, Benisio Ferreira
    Almeida Diniz Gurgel, Ana Pavla
    de Freitas Lins Neto, Manoel Alvaro
    de Azevedo, Dalmo Almeida
    de Freitas, Antonio Carlos
    Silva Neto, Jacinto da Costa
    Ferreira Silva, Luiz Antonio
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (09) : 775 - 778
  • [9] Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
    Hamfjord, J.
    Guren, T.
    Dajani, O.
    Glimelius, B.
    Sorbye, H.
    Pfeiffer, P.
    Christoffersen, T.
    Lingjaerde, O.
    Tveit, K.
    Kure, E.
    Pallisgaard, N.
    Spindler, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [10] Circulating cell-free DNA: a potential biomarker in lung cancer
    Taylor, Fiona
    Teare, M. Dawn
    Cox, Angela
    Woll, Penella J.
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (05) : 407 - 422
12345